CHD9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.176040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.832000E-01
Normal-vs-Stage2
1.047750E-01
Normal-vs-Stage3
1.152360E-01
Normal-vs-Stage4
8.899800E-01
Stage1-vs-Stage2
1.285440E-01
Stage1-vs-Stage3
1.292310E-02
Stage1-vs-Stage4
4.919200E-01
Stage2-vs-Stage3
8.68829999944865E-07
Stage2-vs-Stage4
3.697900E-02
Stage3-vs-Stage4
1.490230E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.074410E-01
Normal-vs-AfricanAmerican
6.208200E-01
Normal-vs-Asian
3.635900E-02
Caucasian-vs-AfricanAmerican
2.605000E-01
Caucasian-vs-Asian
1.060370E-01
AfricanAmerican-vs-Asian
8.590000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.550430E-01
Normal-vs-Female
9.277500E-02
Male-vs-Female
6.635000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.029200E-01
Normal-vs-Age(41-60Yrs)
3.087800E-01
Normal-vs-Age(61-80Yrs)
7.510300E-02
Normal-vs-Age(81-100Yrs)
5.661800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.821600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.916600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.064200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.679560E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.583900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.399400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.147500E-02
Normal-vs-Daily Drinker
1.027560E-02
Normal-vs-Weekly Drinker
1.140960E-01
Normal-vs-Occasional Drinker
2.788000E-01
Normal-vs-Social Drinker
2.728600E-01
Non Drinker-vs-Daily Drinker
2.640400E-01
Non Drinker-vs-Weekly Drinker
9.481200E-01
Non Drinker-vs-Occasional Drinker
1.404200E-01
Non Drinker-vs-Social Drinker
2.681200E-01
Daily Drinker-vs-Weekly Drinker
4.346800E-01
Daily Drinker-vs-Occasional Drinker
2.190100E-02
Daily Drinker-vs-Social Drinker
5.925700E-02
Weekly Drinker-vs-Occasional Drinker
2.509200E-01
Weekly Drinker-vs-Social Drinker
3.843200E-01
Occasional Drinker-vs-Social Drinker
8.356400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.008440E-01
Normal-vs-Grade 2
2.653900E-02
Normal-vs-Grade 3
2.280100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.234000E-01
Grade 1-vs-Grade 3
1.425200E-01
Grade 1-vs-Grade 4
1.008440E-01
Grade 2-vs-Grade 3
1.742820E-01
Grade 2-vs-Grade 4
2.653900E-02
Grade 3-vs-Grade 4
2.280100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.886300E-02
Normal-vs-NonDiabetic
5.169500E-02
Diabetic-vs-NonDiabetic
5.723800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.305600E-02
Normal-vs-NoPancreatitis
6.644400E-02
Pancreatitis-vs-NoPancreatitis
2.615000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.981990E-01
Normal-vs-N1
1.062810E-01
N0-vs-N1
9.624800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.239600E-01
Normal-vs-TP53-NonMutant
3.385200E-01
TP53-Mutant-vs-TP53-NonMutant
6.420800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
